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1. Introduction 
The major retinal ganglioside of mammals has now 
been conclusively identified as GD3, by mass spectro- 
metry analysis [ 1 ] and by enzymatic analysis [2]. The 
retinal GD3 differs from the other retinal gangliosides 
in both fatty acid and sphingosine patterns [1,3,4]. It 
is also more intensively labelled after an intraocular 
injection of IV- [acetyZ-3H]mannosamine [S]. The aim 
of this study was to analyse the degradation of the 
rabbit retinal GD3, in comparison to the other retinal 
gangliosides, in a long-term in vivo experiment. The 
gangliosides were labelled by an intraocular injection 
of N- [ucetyl-3H]mannosamine, and the specific 
activities of the ganglioside sialic acids were determined 
2,4,8 and 12 weeks after the injection. 
The sialic acid of the GD3 ganglioside was more 
intensively labelled than the sialic acids of the other 
gangliosides and was degraded in two phases. The first 
phase, between 2 and 4 weeks after the precursor injec- 
tion showed a half-life of approximately 2 weeks, 
while the half-life of the second phase, from 4 weeks 
on, was 8-l 0 weeks. The sialic acids of the other 
gangliosides, GMl, GDla, GDlb and GTl, did not 
show any decrease in specific activity until 4 weeks 
after the precursor injection. The half-life of their 
degradation was 8-10 weeks, equalling the second 
degradation phase of the GD3 sialic acid. 
*Ganglioside nomenclature according to Svennerholm [ 81. 
2. Experimental 
2.1. Materials, precursor injection and ganglioside 
isolation 
N- [AcetyL3 H] Mannosamine (50 /Xi) 500 mCi/ 
mmol (The Radiochemical Centre, Amersham) in 25 
fl sterile isotone saline, was injected into the vitreous 
body, in both eyes of 28 albino rabbits. The animals 
weighed 1 S-2.0 kg and were anaesthetized by mebu- 
mal before the precursor injection [6]. The animals 
were killed 2,4,8 and 12 weeks after the injection, in 
groups of 7 rabbits, and the retinae were immediately 
taken out, pooled and stored at -20°C until lipid 
extraction. The retinal lipids were extracted by chloro- 
form-methanol 1:2(v/v). The lipid extract was 
saponified and, after neutralization, desalted and freed 
from possible precursor contamination on a 5 g Sepha-’ 
dex G-25 fine column [7]. The gangliosides in the lipid 
eluate were separated from the other lipids on a 5 g 
silica-gel H (Fluka AG, Buchs, Switzerland) column [5]. 
Two batches of gangliosides were collected, one con- 
taining the GD3 ganglioside, the other containing the 
remaining retinal gangliosides GMl, GDl a, GDl b and 
GTl . The gangliosides were quantified by the deter- 
mination of sialic acid with the resorcinol method [8]. 
2.2. Isolation of sialic acids * 
2.2.1. GD3 
Approximately 100 nmol GD3 was hydrolysed with 
sialidase from Vibrio Cholera (Neuraminidase, Behring- 
werke) [9] and the liberated sialic acid was isolated 
from the remaining lipid on a 1 g Sephadex G-25 fine 
column [9]. 
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2.2.2. GMl, GDla, GDlb and GTl 
An aliquot of the ganglioside mixture, corresponding 
to 100-200 nmol sialic acid, was hydrolysed with 
sialidase and later formic acid, and the liberated siali- 
dase labile and stable sialic acids were isolated from 
the remaining lipids on 1 g Sephadex G-25 fine 
columns [9]. 





P 500 - 
z t 
The samples of sialic acid were evaporated and dis- 
solved in 2 ml water. They were quantified by the 
resorcinol method [8] on duplicate samples. The radio- 
activities were determined by scintillation spectro- 
photometry on single samples containing 30-100 nmol 
sialic acid 0.5 ml water mixed with 10 ml Instagel 
(Packard), counted 3 X 1 min. 
* 
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Fig.1. The specific activities of the sialic acids of the rabbit 
retinal gangliosides, after an intraocular injection of 50 &i 
ofN-[uceryl-3H] mannosamine. CD3 o; Mixture of GMl, GDla, 
GDl b and GTl : sialidase labile sialic acid A; sialidase stable 
sialic acid A. 
3. Results and discussion 
The figure shows the specific activities of the sialic 
acid in the GD3 gangliosides and of the sialidase labile 
and stable sialic acids in the ganglioside mixture of 
GM1 ,GDl a, GDl b and GTl . The specific activity of 
the GD3 sialic acid was approximately two-fold higher 
than the specific activities of the sialidase labile and 
stable sialic acids of the other gangliosides, 2 weeks after 
the precursor injection. This is in agreement with the 
differences in specific activities for these gangliosides, 
previously found 12 h after the injection of the same 
precursor, in the short-term experiment [5]. The 
degradation-phase, in terms of decreasing specific 
activities, had started for the GD3 sialic acid already 
2 weeks after the injection. The ganglioside mixture 
of GM1 , GDla, GDl b and GTI , however, still showed 
an increase in specific activities in both sialidase 
labile and stable sialic acids, between 2 and 4 weeks 
after the injection. Such a long incorporation phase 
was also found for these gangliosides in previous 
experiments on the optic pathway [6] and the brain 
[lo]. The sialidase labile sialic acid of the ganglioside 
mixture GMl, GDla, GDlb and GTl had a higher 
specific activity than the sialidase stable sialic acid, up 
to 4 weeks after the precursor injection. This is in 
agreement with the results of the previous hort-term 
experiments on retina [S] and brain [9,10]. 
of the GD3 sialic acid decreased rapidly, with a half- 
life of approximately 2 weeks, in contrast o the still 
increasing specific activity of the sialic acids of the 
other gangliosides. After 4 weeks, the specific activities 
of the sialic acids of both the GD3 and the ganglioside 
mixture of GMl, GDla, GDlb and GTl, were approxi- 
mately the same and decreased equally, with a half-life 
around 8-10 weeks. Such a long half-life was also 
found for the gangliosides in the optic pathway [6] and 
in the brain [lo.]. 
The differences between GD3 and the other gang- 
liosides, in fatty acid and sphingosine patterns, and in 
the incorporation of the precursor N-(acetyl)mannos- 
amine, was suggested to indicate a difference in 
cellular or subcellular localization (see e.g. [5] ). The 
results of this study, showing a two-phase degradation 
curve for the GD3, with a rapid degradation of the 
GD3 between 2 and 4 weeks after the precursor 
injection, the other gangliosides still remaining in the 
incorporation phase, makes it probable that a consider- 
able fraction of the retinal GD3 is to be found in a 
pool with a cellular or subcellular localization which is 
different from the localization of the other retinal 
gangliosides. 
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